Angioedema is a well-known side effect of treatment with an angiotensin-converting enzyme (ACE) inhibitor and one that we have been willing to accept in view of the incidence of the problem and ...

Angioedema is a well-recognized side effect of angiotensin-converting enzyme (ACE) inhibitor therapy. Angioedema can also be seen with angiotensin receptor blocker therapy but much less frequently ...

A 53-year-old woman presented with a recurrent episode of severe, diffuse abdominal pain. CT of the abdomen revealed segmental thickening of the walls of the colon and rectum and mesenteric edema.

Swelling in the deeper layers of the skin (angioedema) often around the face and lips. If swelling causes your throat or tongue to block your airway, this can be life-threatening. Bronchospasm.

1 Yonsei Institute of Sports Science & Exercise Medicine, Wonju, Korea, South 2 Department of Physiology, Yonsei University Wonju College of Medicine, Wonju, Korea, South 3 Department of ...

Other side effects include hypersensitivity, angioedema, and bronchospasm, but effects on bone metabolism or impairment of fracture healing are not currently listed. Studies initially performed in the ...

The full-blown syndrome includes urticaria (hives) and/or angioedema with hypotension and bronchospasm. The former involves prior sensitization with later re-exposure, producing symptoms via an ...

Side effects of both drugs include: cough hoarse voice increased risk of infection oral thrush (see “Side effect specifics” for details) paradoxical bronchospasm (see “Side effect specifics ...

"It looks as if the single-dose treatment will provide a permanent cure for my hereditary angioedema patients' very disabling symptoms," principal investigator Dr Hilary Longhurst, from the ...

The median duration of effect was ~3 hours, with some lasting as long as 6 hours. Bronchospasm Associated with Asthma – Pediatric Patients 4 to 11 Years of Age A 6-week, randomized, double-blind ...

angioedema (including swelling of the lips, tongue, or throat), rash, bronchospasm, anaphylaxis, or itching. Discontinue therapy immediately and consider alternative treatments if hypersensitivity ...

AstraZeneca’s FASENRA® (benralizumab) has been approved in the US for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA).1 EGPA is a rare, immune-mediated ...